Catherine Copley‐Merriman

Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

Richard C. Eastman, Jonathan C. Javitt, William H. Herman et al. · Diabetes Care · 1997 · 337 citations

Pharmacy, Internal Medicine, Pharmacoeconomics +17

Model of Complications of NIDDM: I. Model construction and assumptions

Richard C. Eastman, Jonathan C. Javitt, William H. Herman et al. · Diabetes Care · 1997 · 260 citations

Medicine, Biostatistics, Nephrology +17

High burden and unmet patient needs in chronic kidney disease

V. Sood, Hogue, Lieberman et al. · International Journal of Nephrology and Renovascular Disease · 2012 · 90 citations · Full text

Medicine, Nephrology, Pharmacoeconomics +16

Health‐related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib <i>versus</i> best available therapy

Claire Harrison, Ruben A. Mesa, Jean‐Jacques Kiladjian et al. · British Journal of Haematology · 2013 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Effect of antidepressant therapy on health care utilization and costs in primary care

Thomas W. Croghan, Tamra J. Lair, Luella Engelhart et al. · Psychiatric Services · 1997 · 74 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17